Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel HCV NS3 protease inhibitors under study at BMS

Aug. 6, 2003

Chiron licenses HCV technology to Gilead for drug development efforts

Aug. 6, 2003

Probactrix controls HIV-associated diarrhea in clinical trial

Aug. 4, 2003

FDA approval for Rebetol in pediatric hepatitis C

Aug. 4, 2003

Enrollment completed in phase II trial of Ceplene in hepatitis C nonresponders

July 31, 2003

Beneficial effects found for EGF enema and oral mesalamine in ulcerative colitis

July 31, 2003

CPMP recommends approval of Remicade for maintenance dosing in fistulizing CD

July 30, 2003

Phase III induction trial of Antegren fails to meet primary endpoint

July 29, 2003

Pfizer claims new 5-HT4 receptor modulators and their use in gastrointestinal disorders

July 28, 2003

Spotlight on viral enzyme inhibitors for the treatment of chronic hepatitis B

July 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...